Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2026-03-01 @ 2:42 AM
Study NCT ID:
NCT04470908
Status:
COMPLETED
Last Update Posted:
2024-10-26
First Post:
2020-07-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
The Effect of Moderate CYP3A Inducer Rifabutin on the Pharmacokinetics of Zanubrutinib in Healthy Males
Sponsor:
BeiGene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-29
Start Date Type:
ACTUAL
Primary Completion Date:
2020-11-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-11-10
Completion Date Type:
ACTUAL
First Submit Date:
2020-07-10
First Submit QC Date:
None
Study First Post Date:
2020-07-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-03-10
Results First Submit QC Date:
None
Results First Post Date:
2023-12-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-23
Last Update Post Date:
2024-10-26
Last Update Post Date Type:
ACTUAL